Plain-English translation of NCT07147621 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research is looking at whether chemotherapy used to treat blood cancers—like acute myeloid leukemia, Hodgkin's lymphoma, and non-Hodgkin's lymphoma—affects patients' ability to think clearly, remember things, and concentrate. Researchers will give patients special thinking and memory tests, and compare their results to a matched group of healthy volunteers who are similar in age and education. This will help doctors understand if and how the treatment affects the brain.
Many cancer patients report feeling foggy, forgetful, or unable to concentrate during or after chemotherapy, but this side effect hasn't been well studied in blood cancer patients. By measuring these thinking problems carefully, doctors hope to better understand the problem and eventually help future patients.
You likely qualify if…
You likely don't qualify if…
If you join, you'll complete special thinking and memory tests at different times during your chemotherapy treatment and afterward. You'll also answer questions about your quality of life, tiredness, anxiety, and mood. At the same time, a family member or close friend who matches you in age and education will take the same thinking tests so doctors can compare your results. The study involves visits to the hospital where the tests are done, alongside your regular cancer treatment appointments.
AI-generated summary from trial data · Jul 18, 2026 · Not medical advice
France